|
1
|
Mouse models of diabetic nephropathy.
|
J Am Soc Nephrol
|
2009
|
3.74
|
|
2
|
Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone.
|
J Lipid Res
|
2002
|
2.30
|
|
3
|
Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens.
|
Gastroenterology
|
2005
|
1.81
|
|
4
|
Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production.
|
J Immunol
|
2006
|
1.77
|
|
5
|
Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene.
|
Obesity (Silver Spring)
|
2010
|
1.38
|
|
6
|
Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.23
|
|
7
|
Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice.
|
Diabetes
|
2002
|
1.22
|
|
8
|
Refined histopathologic scoring system improves power to detect colitis QTL in mice.
|
Mamm Genome
|
2004
|
1.20
|
|
9
|
New mouse model to study islet transplantation in insulin-dependent diabetes mellitus.
|
Transplantation
|
2002
|
1.17
|
|
10
|
Four additional mouse crosses improve the lipid QTL landscape and identify Lipg as a QTL gene.
|
J Lipid Res
|
2009
|
1.16
|
|
11
|
Caspase-1 is not required for type 1 diabetes in the NOD mouse.
|
Diabetes
|
2004
|
1.16
|
|
12
|
CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins.
|
J Immunol
|
2005
|
1.12
|
|
13
|
Targeted disruption of CD38 accelerates autoimmune diabetes in NOD/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion.
|
J Immunol
|
2006
|
1.06
|
|
14
|
Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism.
|
Vascul Pharmacol
|
2006
|
1.04
|
|
15
|
Mechanisms underlying resistance of pancreatic islets from ALR/Lt mice to cytokine-induced destruction.
|
J Immunol
|
2005
|
1.04
|
|
16
|
Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic {beta}-cells.
|
J Biol Chem
|
2005
|
1.03
|
|
17
|
Absence of a reductase, NCB5OR, causes insulin-deficient diabetes.
|
Proc Natl Acad Sci U S A
|
2004
|
1.03
|
|
18
|
Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice.
|
Inflamm Bowel Dis
|
2002
|
1.01
|
|
19
|
P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide.
|
J Immunol
|
2005
|
1.00
|
|
20
|
A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein.
|
FEBS Lett
|
2006
|
0.94
|
|
21
|
Cdcs1 a major colitis susceptibility locus in mice; subcongenic analysis reveals genetic complexity.
|
Inflamm Bowel Dis
|
2010
|
0.93
|
|
22
|
Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress.
|
Immunogenetics
|
2003
|
0.92
|
|
23
|
CD38 is required for the peripheral survival of immunotolerogenic CD4+ invariant NK T cells in nonobese diabetic mice.
|
J Immunol
|
2006
|
0.91
|
|
24
|
"Agouti NOD": identification of a CBA-derived Idd locus on Chromosome 7 and its use for chimera production with NOD embryonic stem cells.
|
Mamm Genome
|
2005
|
0.90
|
|
25
|
Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice.
|
J Immunol
|
2011
|
0.88
|
|
26
|
Genetic control of neutrophil superoxide production in diabetes-resistant ALR/Lt mice.
|
Free Radic Biol Med
|
2002
|
0.88
|
|
27
|
Pharmacogenetic analysis of rosiglitazone-induced hepatosteatosis in new mouse models of type 2 diabetes.
|
Diabetes
|
2005
|
0.88
|
|
28
|
mt-Nd2(a) Modifies resistance against autoimmune type 1 diabetes in NOD mice at the level of the pancreatic β-cell.
|
Diabetes
|
2010
|
0.86
|
|
29
|
Major histocompatibility complex-linked diabetes susceptibility in NOD/Lt mice: subcongenic analysis localizes a component of Idd16 at the H2-D end of the diabetogenic H2(g7) complex.
|
Diabetes
|
2005
|
0.86
|
|
30
|
Flow cytometric and immunoblot assays for cell surface ADP-ribosylation using a monoclonal antibody specific for ethenoadenosine.
|
Anal Biochem
|
2003
|
0.86
|
|
31
|
Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids.
|
Cancer Cell Int
|
2007
|
0.85
|
|
32
|
The diabetes-prone NZO/HlLt strain. I. Immunophenotypic comparison to the related NZB/BlNJ and NZW/LacJ strains.
|
Lab Invest
|
2002
|
0.85
|
|
33
|
Commonalities of genetic resistance to spontaneous autoimmune and free radical--mediated diabetes.
|
Free Radic Biol Med
|
2008
|
0.85
|
|
34
|
Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis.
|
Diabetes
|
2005
|
0.85
|
|
35
|
ALS/Lt: a new type 2 diabetes mouse model associated with low free radical scavenging potential.
|
Diabetes
|
2004
|
0.84
|
|
36
|
Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1Lt mice with polygenic obesity.
|
Metabolism
|
2004
|
0.84
|
|
37
|
Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis.
|
Diabetes
|
2006
|
0.84
|
|
38
|
Animal models of diabetic uropathy.
|
J Urol
|
2009
|
0.82
|
|
39
|
The diabetes-prone NZO/Hl strain. II. Pancreatic immunopathology.
|
Lab Invest
|
2002
|
0.78
|
|
40
|
Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.
|
J Autoimmun
|
2003
|
0.76
|
|
41
|
Tracking autoimmune T cells in diabetes.
|
J Clin Invest
|
2003
|
0.75
|
|
42
|
Bone marrow expressing a diabetes resistance MHC class II allele: diabetes deviation by chronic immune stimulation.
|
Novartis Found Symp
|
2008
|
0.75
|
|
43
|
Anti-insulin receptor autoantibodies are not required for type 2 diabetes pathogenesis in NZL/Lt mice, a New Zealand obese (NZO)-derived mouse strain.
|
Exp Diabesity Res
|
2004
|
0.75
|
|
44
|
The diabetes-prone NZO/Hl strain. Proliferation capacity of beta cells in hyperinsulinemia and hyperglycemia.
|
Arch Physiol Biochem
|
2006
|
0.75
|